Delivery Order SPE2DB22D2206-SPE2DB24FFY71
- Not listed
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,066.30 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 7, 2023 and was awarded on September 6, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The $41,340.92 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 28, 2024, with a completion date of February 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,543.94, is a firm fixed-price delivery order awarded on December 2, 2021, with a completion date of December 3, 2021. The contract was not set aside for a specific business type. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,810.67, is a delivery order for the supply of medical products, including the pharmaceutical product "TREMFYA 100 MG/ML SYRINGEML". The contract has an ultimate completion date of March 7, 2024 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,217.81 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 1, 2024 with a completion date of March 4, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with a value of $11,495.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TREMFYA 100 MG/ML INJECTORML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that was awarded to the parent company, Cencora, Inc. (doing business as Amerisourcebergen). The contract has a total ceiling value of $9,781.89 and a completion date of...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that provides medical supplies to military treatment facilities. The $25,812.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, and does not utilize any set-aside designations. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,764.09, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of May 10, 2024 and was awarded on May 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
- This federal contract award, with ID SPE2DX15D3014|SPE2DX24FXDPK, is for the delivery of TREMFYA 100 MG/ML SYRINGE medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $16,406.33 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 29, 2024 and was awarded on April 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFY71Delivery Order
This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $17,179.37 and has an ultimate completion date of March 7, 2024. The award was made on March 6, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 3/6/24 |